Artesunate
Bowel Cancer
Metanoic Health Ltd.Small moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Bowel Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Recombinant Human Interleukin-2 Yi Miao | Phase 1 | CC |
her2bi-armed activated t cells Yi Miao | Phase 1 | C |
SODIUM PHOSPHATE Egymedicalpedia | N/A | D |
CEFOXITIN Egymedicalpedia | N/A | D |
Rifaximin National and Kapodistrian University of Athens | N/A | D |
Same molecule, other indications
Artesunate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →